source
- Lilly-backed TRex Bio raises $117M in IPO as hypertension biotech Retension secures $45M listingTRex Bio, a biotech backed by Eli Lilly, completed its initial public offering, generating $116.7 million in gross proceeds. The company sold 8.3 million shares at $14 each, landing at the lower en…
- Hospitals file second lawsuit to block Trump admin's 340B rebate pilotThe American Hospital Association (AHA) has filed another lawsuit against the federal government, challenging a new version of the 340B drug discount program proposed by the Trump administration.…